Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 3 | |
Outperform | 10 | |
Hold | 5 | |
Sell | 1 | |
Strong Sell | 0 |
Share price forecast in USD
The 18 analysts offering 12 month price targets for ACADIA Pharmaceuticals Inc have a median target of 26.50, with a high estimate of 39.00 and a low estimate of 12.00. The median estimate represents a 61.39% increase from the last price of 16.42.
High | 137.5% | 39.00 |
Med | 61.4% | 26.50 |
Low | -26.9% | 12.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Oct 31, 2024.
Average growth rate | +17.86% |
Average growth rate | +18.56% |
More ▼
Revenue history & estimates in USD
Average growth rate | +10.97% |
Average growth rate | +21.79% |
More ▼